RUSSO, EMILIO
 Distribuzione geografica
Continente #
NA - Nord America 315
EU - Europa 285
AS - Asia 69
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 672
Nazione #
US - Stati Uniti d'America 314
IE - Irlanda 140
SE - Svezia 100
SG - Singapore 36
CN - Cina 27
DE - Germania 20
IT - Italia 13
BE - Belgio 3
IN - India 3
CZ - Repubblica Ceca 2
FR - Francia 2
CA - Canada 1
CO - Colombia 1
FI - Finlandia 1
GB - Regno Unito 1
ID - Indonesia 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TR - Turchia 1
Totale 672
Città #
Dublin 140
Chandler 100
Nyköping 80
Singapore 25
Ashburn 24
Princeton 22
Medford 21
Munich 20
Beijing 7
Des Moines 7
Messina 7
Jacksonville 5
Shenyang 5
Brussels 3
Dearborn 3
Falls Church 3
Fuzhou 3
Hyderabad 3
Los Angeles 3
Santa Clara 3
Brno 2
Cambridge 2
Guangzhou 2
Haikou 2
Jinan 2
New York 2
Seattle 2
Zhengzhou 2
Amsterdam 1
Ann Arbor 1
Auckland 1
Bishkek 1
Boardman 1
Bogotá 1
Catania 1
Cellamare 1
Changsha 1
Chicago 1
Francofonte 1
Hangzhou 1
Jakarta 1
Rabat 1
Riga 1
San Mateo 1
Taizhou 1
Toronto 1
Vicenza 1
Washington 1
Totale 520
Nome #
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 63
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 52
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 51
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 48
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 40
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 38
Genetics of reflex seizures and epilepsies in humans and animals 36
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide 29
Management of status epilepticus in patients with liver or kidney disease: a narrative review 28
Diagnostic Biomarkers of Epilepsy 26
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 26
Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study 26
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 25
Epilepsy associated with Leukoaraiosis mainly affects temporal lobe: a casual or causal relationship? 24
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis 23
Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study 23
Epilepsy and Immune System: A Tour Around the Current Literature 21
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 21
Profile of brivaracetam and its potential in the treatment of epilepsy 21
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 19
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 17
An empirical investigation of the unbiased forward exchange rate hypothesis in a regime switching market 16
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy 16
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 3
Totale 692
Categoria #
all - tutte 3.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 4 1 0 0 6 0 2
2020/202135 1 0 9 0 5 0 0 10 8 0 2 0
2021/202294 1 8 0 1 4 2 6 0 2 16 4 50
2022/2023373 24 62 23 19 8 39 2 12 174 2 6 2
2023/202474 5 20 5 20 5 7 0 2 0 4 0 6
2024/202591 18 3 19 9 39 3 0 0 0 0 0 0
Totale 692